Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
03/2010
03/23/2010US7683026 can be implemented with any of the stereoisomers of each of the Lysine (K), Proline (P) or Valine (V) amino acid residues
03/23/2010US7682631 Adhesin-specific nanoparticles and process for using same
03/23/2010US7682612 Chronic Lymphocytic Leukemia (CLL) is treated with antibodies directed against the CD20 antigen; rituximab; chemotherapy
03/23/2010US7682601 Bifunctional tridentate pyrazolyl containing ligands for re and tc tricarbonyl complexes
03/23/2010CA2408992C Pharmaceutical preparation for the diagnosis of helicobacter pylori infection
03/23/2010CA2375374C Induction of pharmacological stress with adenosine receptor agonists
03/18/2010WO2010030120A2 Fluorescent silica nanoparticle with radioactive tag and the detecting method of pet and fluorescent dual imaging using thereof
03/18/2010WO2010028817A2 Medical system
03/18/2010WO2010028776A1 Piperazine derivatives for binding and imaging amyloid plaques and their use
03/18/2010US20100069628 Multidentate AZA Ligands Able to Complex Metal Ions And The Use Thereof In Diagnostics And Therapy
03/18/2010US20100068140 Myelin detection using benzofuran derivatives
03/18/2010US20100068139 Methods of radiofluorination of biologically active vectors
03/18/2010US20100068138 Structurally rigid dopamine d3 receptor selective ligands and process for making them
03/18/2010US20100068137 Dock-and-Lock (DNL) Vaccines for Cancer Therapy
03/18/2010US20100068136 Anti-CD19 Antibodies
03/18/2010US20100068135 Antibody compositions, methods for treating neoplastic disease and methods for regulating fertility
03/18/2010CA2736530A1 Piperazine derivatives for binding and imaging amyloid plaques and their use
03/17/2010EP2163564A1 Cancerous disease modifying antibodies
03/17/2010EP2163541A1 Piperazine derivatives for binding and imaging amyloid plaques and their use
03/17/2010EP2163256A1 Specific binding proteins and uses thereof
03/17/2010CN101675158A Cancerous disease modifying antibodies
03/17/2010CN101671247A Novel technology for separating and refining positron medicine of <11>C-sodium acetate
03/17/2010CN101670120A Drug for diagnosis of gastric cancer and preparation method thereof
03/16/2010US7678887 Identification and cloning of a novel human gene, RET16, involved in the intracellular signaling cascade
03/16/2010US7678771 comprising L-lysine-d-amphetamine or salts; for treating attention deficit hyperactivity disorder
03/16/2010US7678770 Abuse-resistant amphetamine prodrugs
03/16/2010US7678763 preparations of insulin and glucagon; for use when glucagon response to acute hypoglycemia is impaired or lost in patients with advanced Type 1 and Type 2 diabetes
03/16/2010US7678762 Methods for reducing the risk of hypoglycemia
03/16/2010CA2302838C Modulation of the sphingosine kinase signalling pathway
03/11/2010WO2010028389A1 Image-guided energy deposition for targeted drug delivery
03/11/2010WO2010028216A2 Porphyrazine optical and dual optical/mr contrast and therapeutic agents
03/11/2010WO2010026388A1 Isatin derivatives for use as in vivo imaging agents
03/11/2010WO2010006755A3 Cyclic polyamines for binding phosphatidylserine
03/11/2010WO2010004512A3 Dicarba-analgues of octreotide
03/11/2010US20100062143 Method and device for radiotherapy
03/11/2010US20100061931 Method for the use of [11c] carbon monoxide in labeling synthesis of 11c-labelled esters by photo-induced free radical carbonylation
03/11/2010US20100061930 ErbB-2 RECEPTOR TARGETING PEPTIDE
03/11/2010US20100061929 Neoplasia targeting peptides and methods of using the same
03/11/2010US20100061928 Labelled analogues of halobenzamides as radiopharmaceuticals
03/11/2010CA2735970A1 Isatin derivatives for use as in vivo imaging agents
03/10/2010EP2160202A2 Compositions emitting positrons and containing inorganic particles, and use thereof in medicine, especially for diagnostic processes
03/10/2010CN101668547A Hypoxia-selective, weakly basic 2-nitroimidazole delivery agents and methods of use thereof
03/09/2010US7674886 Chelation compounds, radionuclides
03/09/2010US7674774 Abuse-resistant amphetamine prodrugs
03/09/2010CA2172153C Regulation of bcl-2 gene expression
03/04/2010WO2010024769A1 New benzofurans suitable as precursors to compounds that are useful for imaging amyloid deposits
03/04/2010WO2010024673A1 Radiolabeled annexins
03/04/2010WO2009137428A3 Methods of determining renal function using technetium-99m tricarbonyl-nitrilotriacetic acid
03/04/2010WO2009046294A3 Treatment of proliferative disorders using antibodies to psma
03/04/2010WO2009023955A8 Cytotoxicity mediation of cells evidencing surface expression of cd9
03/04/2010WO2009022347A3 Device and method for treating respiratory and other diseases
03/04/2010WO2009009179A3 Non-invasive molecular imaging of cellular histone deacetylase substrate using magnetic resonance spectroscopy (mrs) or positron emission tomography (pet)
03/04/2010US20100055036 Pet visualization of amyloid-associated neuroinflammation in the brain
03/04/2010US20100055035 Bisaminoethanethiol-targeting ligand conjugates and compositions
03/04/2010US20100055034 Human Anti-Folate Receptor Alpha Antibodies and Antibody Fragments for the Radioimmunotherapy of Ovarian Carcinoma
03/04/2010US20100055033 Antibody compositions and methods for treatment of neoplastic disease
03/04/2010US20100055032 Methods for vascular imaging using nanoparticulate contrast agents
03/04/2010DE102008045644A1 Preparing radiopharmaceuticals, useful in pharmaceutical and biochemical field e.g. diagnostic purpose, comprises producing radionuclide fluorine-18, adding precursor of radiopharmaceutical and fluorinating it by nucleophilic substitution
03/04/2010DE102008045643A1 Producing radiopharmaceutical comprises producing radionuclide, adding potassium carbonate, separating water, exchanging first solvent, adding radiopharmaceutical precursor, fluorinating, separating solvent, and exchanging second solvent
03/04/2010CA2735497A1 New compounds suitable as precursors to compounds that are useful for imaging amyloid deposits
03/04/2010CA2735214A1 Radiolabeled annexins
03/04/2010CA2735118A1 Butyrylcholinesterase ligands as diagnostic tools and treatment for diseases of the nervous system
03/03/2010EP1572249B1 Solid-phase fluorination of uracil
03/03/2010EP1505973B1 Combinations for treating multiple myeloma
03/03/2010CN101659704A Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination
03/03/2010CN101658672A Combination therapy with class iii anti-cea monoclonal antibodies and therapeutic agents
03/03/2010CN100592921C Activatable particles, preparations and uses.
03/02/2010US7671175 animal feed additive; detergent; defensins; exhibit reduced hemolytic activity, cytotoxicity and sensitivity towards cations, such as Ca2+, Mg2+, Na+.
03/02/2010US7671031 delivering an amphetamine by administering to said subject in need L-lysine-d-amphetamine or a salt thereof; providing an abuse-resistant alternative treatment for certain disorders, such as attention deficit hyperactivity disorder (ADHD), ADD, narcolepsy, and obesity
03/02/2010US7671030 Administering L-lysine-d-amphetamine or salts
03/02/2010US7670804 antibody binds target tissue and conjugate carrying epitope (haptens); monoclonal antibody or fragment thereof binds to a colon-specific antigen-p mucin (CSAp) antigen - the Mu-9 epitope; DNA sequence; anticancer
03/02/2010US7670591 Heteroaryl substituted benzoxazoles
03/02/2010US7670590 Perturbed membrane-binding compounds and methods of using the same
02/2010
02/25/2010WO2009141137A3 New molecule [124i][2-(3'-iodo-4'-methylaminophenyl)-6-hydroxy-benzothialzole] for pet investigations and radiotherapy
02/25/2010WO2009086067A3 Particles for injection and processes fo forming the same
02/25/2010WO2009077599A3 Nanospheres with external surface of noble metal
02/25/2010WO2008129548A3 A system for delivering therapeutic agents into living cells and cells nuclei
02/25/2010US20100047169 NK Cell Receptor Conjugates for Treating Malignancies
02/25/2010US20100047168 Soluble Zcytor 11 Cytokine Receptors
02/25/2010US20100047167 Combination therapy in the treatment of cancer
02/25/2010US20100047166 Antibodies and related molecules that bind to 58p1d12 proteins
02/25/2010US20100047165 Method for diagnosis of chronic allograft rejection
02/25/2010US20100047164 Anti-Tumor Antibodies
02/25/2010US20100047163 Synthetic LDL as Targeted Drug Delivery Vehicle
02/25/2010US20100047162 Methods of processing multi-phasic dispersons
02/25/2010CA2734265A1 Dock-and-lock (dnl) vaccines for cancer therapy
02/24/2010EP2157092A1 Remedy for diabetes
02/24/2010EP2155791A1 Humanized and chimeric anti-trop-2 antibodies that mediate cancer cell cytotoxicity
02/24/2010EP2155781A1 Labelled adrenomedullin derivatives and their use for imaging and therapy.
02/24/2010EP2155263A2 Use of radiolabelled phenyloxyaniline derivatives for imaging diseases associated with peripheral benzodiazepin receptor's activation
02/24/2010EP2155262A2 Compositions for targeted imaging and therapy
02/24/2010EP1553962B1 Combination chemotherapy with chlorotoxin
02/24/2010EP0837696B1 Improved delivery of diagnostic and therapeutic agents to a target site
02/24/2010CN101654479A Mammalian receptor proteins, agents, and methods relating thereto
02/24/2010CN101653614A Novel bone seeking <99m>Tc complex, preparation thereof and application thereof
02/24/2010CN100591361C Conjugates for medical imaging comprising carrier, targeting moiety and a contrast agent
02/23/2010US7668662 Patient-specific dosimetry
02/23/2010US7666985 HLA-A24-restricted cancer antigen peptides
02/23/2010US7666415 Production and use of novel peptide-based agents for use with bi-specific antibodies
02/23/2010US7666391 Therapeutic treating breast cancer
1 ... 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 ... 243